| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 02/01/2001 | WO2001007050A1 Nociceptin receptor orl-1 agonists for use in treating cough |
| 02/01/2001 | WO2001007029A2 Substituted guanidines and the use thereof |
| 02/01/2001 | WO2001007020A2 Carboxylic acid amides, medicaments containing these compounds and the use and production thereof |
| 02/01/2001 | WO2000038717A3 Use of a matrix metalloproteinase inhibitor and radiation as a combined treatment of neoplasia |
| 02/01/2001 | WO2000037107A3 Use of cyclooxygenase-2 inhibitor, a matrix metallaproteinase inhibitor, an antineoplastic agent and optionally radiation as a combination treatment of neoplasia |
| 02/01/2001 | DE19935219A1 Carbonsäureamide, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Herstellung Carboxamides, medicaments containing these compounds, their use and production |
| 02/01/2001 | CA2379398A1 Nociceptin receptor orl-1 agonists for use in treating cough |
| 01/31/2001 | EP1072601A2 4-arylpiperidine derivatives for the treatment of pruritus |
| 01/31/2001 | EP1072596A2 4-arylpiperidine derivatives for the treatment of pruritus |
| 01/31/2001 | EP1072595A2 4-arylpiperidine derivatives for the treatment of pruritus |
| 01/31/2001 | EP1072594A2 4-arylpiperidine derivatives for the treatment of pruritus |
| 01/31/2001 | EP1072593A1 Liquid crystalline compound having piperidine ring, liquid crystal composition and liquid crystal display element |
| 01/31/2001 | EP1072592A2 4-arylpiperidine derivatives for the treatment of pruritus |
| 01/31/2001 | EP1072587A1 Sulfonamide derivatives and drugs containing the same as the active ingredient |
| 01/31/2001 | EP1071807A1 Method for enzymatic enantiomer-separation of 3(r)- and 3(s)-hydroxy-1- methyl-4-(2,4, 6-trimethoxyphenyl)-1, 2,3,6- tetrahydro-pyridine or its carboxylic acid esters |
| 01/31/2001 | EP1071681A1 Nitroxyl derivatives with glycidyl or alkylcarbonyl groups as initiators for radical polymerisation |
| 01/31/2001 | EP1071666A1 Azacycloalkane derivatives, preparation and therapeutic application |
| 01/31/2001 | EP1071656A1 Fluorovinyloxyacetamides, process for preparing same and herbicidal composition comprising same |
| 01/31/2001 | EP0842152B1 N-(4-substituted-benzyl)-2-aminolactam derivatives |
| 01/31/2001 | EP0837680B1 Use of phenoxy pyridine derivatives for the treatment of illnesses caused by disorders of the dopamine system |
| 01/31/2001 | CN1282326A Anilide derivative, production and use thereof |
| 01/31/2001 | CN1282319A Aminobutanoic acid derivatives |
| 01/31/2001 | CN1282318A Optically active intermediates for preparation of optically active substituted oximex, hydrazones and olefins useful as neurokinin antagonists |
| 01/31/2001 | CN1281850A Preparation method of 4-chloro-2,2,6,6-tetramethyl piperidine |
| 01/30/2001 | US6180796 Sulfonamide derivatives |
| 01/30/2001 | US6180759 Process for the preparation of azacycloalkylakanoyl pseudotetrapeptides |
| 01/30/2001 | US6180648 Analogs of cocaine |
| 01/30/2001 | US6180647 Gastrointestinal disorders; nervous system disorders |
| 01/30/2001 | US6180646 Retroviral protease inhibitors |
| 01/25/2001 | WO2001006261A2 Screening for therapeutic agents being scap antagonists |
| 01/25/2001 | WO2001005765A1 Cyclic amides and imides having selective antagonist activity at alpha-1d adrenergic receptor |
| 01/25/2001 | WO2001005764A2 Sulfuric acid mono-[3-({1- [2-(4-fluoro-phenyl)-ethyl]- piperidin-4-yl}- hydroxy- methyl)-2- methoxy-phenyl]ester |
| 01/25/2001 | WO2001005763A2 Compounds with activity on muscarinic receptors |
| 01/25/2001 | WO2001005762A2 Biphenyl derivatives, production thereof and use as mtp inhibitors |
| 01/25/2001 | WO2001005392A2 Method for treating chronic pain using mek inhibitors |
| 01/25/2001 | WO2000071515A3 INHIBITORS OF FACTOR Xa |
| 01/25/2001 | WO2000066550A8 New compounds |
| 01/25/2001 | DE19934394A1 New N-phenylnaphthalenesulfonamide derivatives useful for treatment and prevention of viral infection, especially cytomegalovirus |
| 01/25/2001 | DE19934321A1 New N-phenyl-naphthalenesulfonamide derivatives are antiviral agents especially useful for treating cytomegalovirus infections |
| 01/25/2001 | DE19933926A1 Biphenylderivate, ihre Herstellung und ihre Verwendung als Arzneimittel Biphenyl derivatives, their preparation and their use as medicaments |
| 01/25/2001 | CA2374052A1 Method for treating chronic pain using mek inhibitors |
| 01/24/2001 | EP1070049A1 Benzamide and sulfonamide substituted aminoguanidines and alkoxyguanidines as protease inhibitors |
| 01/24/2001 | EP1070046A1 Propanolamine derivatives |
| 01/24/2001 | CN1281435A N-Oxyl compounds, process for preparation thereof and process for inhibiting polymerization of vinyl monomers with same |
| 01/24/2001 | CN1281434A Urethanes derived from azacycloalkanes, thio and dithio analogues, production and use thereof as 2,3 epoxysqualene lanesterol cyclase inhibitors |
| 01/24/2001 | CN1281433A Hydroxamic acid derivatives as matrix metalloprotease (MMP) inhibitors |
| 01/24/2001 | CN1281430A N-alkanoylphenylalanine derivatives |
| 01/24/2001 | CN1281335A Treatment of schizophrenia with ampakines and neuroleptics |
| 01/24/2001 | CN1061076C Mixtures of polyalkylpiperidin-4-yl dicarboxylic acid esters as stabilizers for organic materials |
| 01/24/2001 | CN1061041C Piperidine derivatives |
| 01/24/2001 | CN1061035C Phenylalkanolamine derivatives and its preparing process and use |
| 01/23/2001 | US6177447 Therapy for gaucher's disease |
| 01/23/2001 | CA2197451C Neuroprotective 3-(piperidinyl-1)-chroman-4,7-diol and 1-(4-hydrophenyl)-2-(piperidinyl-1)-alkanol derivatives |
| 01/18/2001 | WO2001004170A1 Thermoplastic polymer having polar group, use thereof, and unsaturated compounds having polar group |
| 01/18/2001 | WO2001004119A1 Amido spiropiperidines promote the release of growth hormone |
| 01/18/2001 | WO2001004116A2 Neurotrophic pyrrolidines and piperidines, and related compositions containing them |
| 01/18/2001 | WO2001004093A2 Process for producing paroxetine derivatives by mitsunobu reaction |
| 01/18/2001 | WO2001004087A1 Sulfonamide substituted benzylamine derivatives and their use as medicaments |
| 01/18/2001 | WO2000071516A3 INHIBITORS OF FACTOR Xa |
| 01/18/2001 | WO1999064049A9 Novel antibacterial agents |
| 01/18/2001 | CA2379149A1 Neurotrophic pyrrolidines and piperidines, and related compositions and methods |
| 01/18/2001 | CA2378600A1 Amino ceramide-like compounds and therapeutic methods of use |
| 01/17/2001 | EP1068193A1 Benzylpiperazinyl- and benzylpiperidinyl ethanone derivatives, their preparation and their use as dopamine d 4? receptor antagonists |
| 01/17/2001 | EP1068185A1 Compounds with activity on muscarinic receptors |
| 01/17/2001 | EP1068172A1 PLATELET AGGREGATION INHIBITION USING LOW MOLECULAR WEIGHT HEPARIN IN COMBINATION WITH A GP IIb/IIIa ANTAGONIST |
| 01/17/2001 | EP0983258A4 N-hydroxy 4-sulfonyl butanamide compounds |
| 01/17/2001 | EP0725059B1 2,3-diaminopropionic acid derivative |
| 01/17/2001 | CN1280578A Bis-quaternary ammonium derivatives as neuromuscular relaxants |
| 01/17/2001 | CN1280564A Method for producing salts of cyclic amidines |
| 01/16/2001 | US6174924 Treating nerve cell death comprising administering to a subject exhibiting symptoms of nerve cell death or susceptible to nerve cell death a substituted guanidine compound |
| 01/16/2001 | US6174905 As carcinostatic agent to a hematologic malignancy and a solid carcinoma |
| 01/16/2001 | US6174900 Substituted piperidine derivative for treating urinary disturbance |
| 01/16/2001 | US6174898 Method of treating filariae |
| 01/16/2001 | US6174887 Amide compounds and use of the same |
| 01/11/2001 | WO2001002417A1 Nucleotide monomer containing six-membered azarsugar and antisense oligomers thereof |
| 01/11/2001 | WO2001002381A1 Piperazine derivatives as modulators of chemokine receptor activity |
| 01/11/2001 | WO2001002376A1 Amino-alkyl derivatives |
| 01/11/2001 | WO2001002368A1 N-heterocyclic derivatives with neuronal activity |
| 01/11/2001 | WO2001002360A1 Process for preparing amlodipine benzenesulphonate |
| 01/11/2001 | WO2001002359A1 Heterocyclic compounds and medicinal use thereof |
| 01/11/2001 | WO2001002358A2 Cyclized amide derivatives for treating or preventing neuronal damage |
| 01/11/2001 | WO2001002357A2 Process for the synthesis of 4-(4'-fluorophenyl)-piperidines |
| 01/11/2001 | WO2001002345A2 Mono and multifunctional alkoxyamines for the preparation of functionalized macromers |
| 01/11/2001 | CA2377771A1 Heterocyclic compounds and medical use thereof |
| 01/11/2001 | CA2375806A1 Mono and multifunctional alkoxyamines for the preparation of functionalized macromers |
| 01/10/2001 | EP1067136A1 New peptide derivatives |
| 01/10/2001 | EP1067120A1 Process for producing organic compound having nitroxide free radical |
| 01/10/2001 | EP1066259A1 Biocidal benzylbiphenyl derivatives |
| 01/10/2001 | EP1066245A1 Novel local anesthetic compounds and uses |
| 01/10/2001 | EP1066035A2 Substituted aromatic compounds for treatment of antibiotic resistant infections |
| 01/10/2001 | CN1279681A Piperidylaminomethyltrifluoromethyl cyclic ether compound as p substance antagonist |
| 01/10/2001 | CN1279674A 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analoguse), their preparation and their use in the treatment of neurological disorders |
| 01/10/2001 | CN1279673A ((Cyclo) alkyl substituted-.gamma.-aminobutyric acid derivatives (=GABA analogurs), their preparation and their use in the treatment of neurolog disorders |
| 01/10/2001 | CN1279670A Substituted oximes as neurokinin antagonists |
| 01/10/2001 | CN1279669A Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| 01/10/2001 | CN1279667A 4(3)-substituted-4(3)-aminonethyl-(thioxo)pyran(thiapyran)or-piperidine derivatives(=gabapendin analogues), their preparation and their use in treatment of neurological disorders |
| 01/09/2001 | US6172234 Optically active cyclic amino acid ester derivatives and processes for producing the same |
| 01/09/2001 | US6172233 Process for making paroxetine |
| 01/09/2001 | US6172082 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 01/09/2001 | US6172067 Analgesics, antiinflammatory agents |